Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 47 entries
Sorted by: Best Match Show Resources per page
Episodic cauda equina compression from an intradural lumbar herniated disc: a case of 'floppy disc'.

Journal of surgical case reports

Nagaria J, Chan C, Kamel M, McEvoy L, Bolger C.
PMID: 24950507
J Surg Case Rep. 2011 Sep 01;2011(9):6. doi: 10.1093/jscr/2011.9.6.

Intradural disc herniation (IDDH) is a rare complication of intervertebral disc disease and comprises 0.26-0.30% of all herniated discs, with 92% of them located in the lumbar region (1). We present a case of IDDH that presented with intermittent...

Cite
Nagaria J, Chan C, Kamel M, et al. Episodic cauda equina compression from an intradural lumbar herniated disc: a case of 'floppy disc'. J Surg Case Rep. 2011;2011(9):6doi: 10.1093/jscr/2011.9.6.
Nagaria, J., Chan, C., Kamel, M., McEvoy, L., & Bolger, C. (2011). Episodic cauda equina compression from an intradural lumbar herniated disc: a case of 'floppy disc'. Journal of surgical case reports, 2011(9), 6. https://doi.org/10.1093/jscr/2011.9.6
Nagaria, J, et al. "Episodic cauda equina compression from an intradural lumbar herniated disc: a case of 'floppy disc'." Journal of surgical case reports vol. 2011,9 (2011): 6. doi: https://doi.org/10.1093/jscr/2011.9.6
Nagaria J, Chan C, Kamel M, McEvoy L, Bolger C. Episodic cauda equina compression from an intradural lumbar herniated disc: a case of 'floppy disc'. J Surg Case Rep. 2011 Sep 01;2011(9):6. doi: 10.1093/jscr/2011.9.6. PMID: 24950507; PMCID: PMC3649298.
Copy Download .nbib Format: NLM
Vaginal Amelanotic Nodular Malignant Melanoma in A Middle-Aged Female: A Rare Case Report and Review of Literature.

Journal of obstetrics and gynaecology of India

Satyanarayan, Nangal J, Kapoor A, Sharma N.
PMID: 26085744
J Obstet Gynaecol India. 2015 May;65(3):199-201. doi: 10.1007/s13224-014-0547-y. Epub 2014 May 18.

No abstract available.

Cite
Satyanarayan, Nangal J, Kapoor A, et al. Vaginal Amelanotic Nodular Malignant Melanoma in A Middle-Aged Female: A Rare Case Report and Review of Literature. J Obstet Gynaecol India. 2014;65(3):199-201doi: 10.1007/s13224-014-0547-y.
Satyanarayan, Nangal, J., Kapoor, A., & Sharma, N. (2015). Vaginal Amelanotic Nodular Malignant Melanoma in A Middle-Aged Female: A Rare Case Report and Review of Literature. Journal of obstetrics and gynaecology of India, 65(3), 199-201. https://doi.org/10.1007/s13224-014-0547-y
Satyanarayan, et al. "Vaginal Amelanotic Nodular Malignant Melanoma in A Middle-Aged Female: A Rare Case Report and Review of Literature." Journal of obstetrics and gynaecology of India vol. 65,3 (2015): 199-201. doi: https://doi.org/10.1007/s13224-014-0547-y
Satyanarayan, Nangal J, Kapoor A, Sharma N. Vaginal Amelanotic Nodular Malignant Melanoma in A Middle-Aged Female: A Rare Case Report and Review of Literature. J Obstet Gynaecol India. 2015 May;65(3):199-201. doi: 10.1007/s13224-014-0547-y. Epub 2014 May 18. PMID: 26085744; PMCID: PMC4464562.
Copy Download .nbib Format: NLM
Left atrial spindle cell sarcoma: a case report.

European heart journal. Case reports

Braams NJ, Kaffka Genaamd Dengler SE, Rutten EGGM, de Boer K.
PMID: 31020250
Eur Heart J Case Rep. 2019 Feb 06;3(1):ytz005. doi: 10.1093/ehjcr/ytz005. eCollection 2019 Mar.

BACKGROUND: Primary cardiac spindle cell sarcomas are extremely rare with only a few cases reported. They are frequently misdiagnosed on cardiac magnetic resonance (CMR) imaging as benign myxoma or thrombi and the suspicion of a malignant sarcoma arises only...

Cite
Braams NJ, Kaffka Genaamd Dengler SE, Rutten EGGM, et al. Left atrial spindle cell sarcoma: a case report. Eur Heart J Case Rep. 2019;3(1):ytz005doi: 10.1093/ehjcr/ytz005.
Braams, N. J., Kaffka Genaamd Dengler, S. E., Rutten, E. G. G. M., & de Boer, K. (2019). Left atrial spindle cell sarcoma: a case report. European heart journal. Case reports, 3(1), ytz005. https://doi.org/10.1093/ehjcr/ytz005
Braams, Natalia J, et al. "Left atrial spindle cell sarcoma: a case report." European heart journal. Case reports vol. 3,1 (2019): ytz005. doi: https://doi.org/10.1093/ehjcr/ytz005
Braams NJ, Kaffka Genaamd Dengler SE, Rutten EGGM, de Boer K. Left atrial spindle cell sarcoma: a case report. Eur Heart J Case Rep. 2019 Feb 06;3(1):ytz005. doi: 10.1093/ehjcr/ytz005. eCollection 2019 Mar. PMID: 31020250; PMCID: PMC6439379.
Copy Download .nbib Format: NLM
Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses.

Cancer drug resistance (Alhambra, Calif.)

Gurule NJ, Heasley LE.
PMID: 30656289
Cancer Drug Resist. 2018;1:118-125. doi: 10.20517/cdr.2018.12. Epub 2018 Sep 19.

Receptor tyrosine kinases (RTKs) bearing oncogenic mutations in EGFR, ALK and ROS1 occur in a significant subset of lung adenocarcinomas. Tyrosine kinase inhibitors (TKIs) targeting tumor cells dependent on these oncogenic RTKs yield tumor shrinkage, but also a variety...

Cite
Gurule NJ, Heasley LE. Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses. Cancer Drug Resist. 2018;1:118-125doi: 10.20517/cdr.2018.12.
Gurule, N. J., & Heasley, L. E. (2018). Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses. Cancer drug resistance (Alhambra, Calif.), 1118-125. https://doi.org/10.20517/cdr.2018.12
Gurule, Natalia J, and Heasley, Lynn E. "Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses." Cancer drug resistance (Alhambra, Calif.) vol. 1 (2018): 118-125. doi: https://doi.org/10.20517/cdr.2018.12
Gurule NJ, Heasley LE. Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses. Cancer Drug Resist. 2018;1:118-125. doi: 10.20517/cdr.2018.12. Epub 2018 Sep 19. PMID: 30656289; PMCID: PMC6333470.
Copy Download .nbib Format: NLM
Complete mitochondrial genome of the porbeagle shark, .

Mitochondrial DNA. Part B, Resources

Díaz-Jaimes P, Uribe-Alcocer M, Adams DH, Rangel-Morales JM, Bayona-Vásquez NJ.
PMID: 33473607
Mitochondrial DNA B Resour. 2016 Oct 03;1(1):730-731. doi: 10.1080/23802359.2016.1233465.

We report for the first time, the complete mitochondrial genome sequence of the porbeagle shark,

Cite
Díaz-Jaimes P, Uribe-Alcocer M, Adams DH, et al. Complete mitochondrial genome of the porbeagle shark, . Mitochondrial DNA B Resour. 2016;1(1):730-731doi: 10.1080/23802359.2016.1233465.
Díaz-Jaimes, P., Uribe-Alcocer, M., Adams, D. H., Rangel-Morales, J. M., & Bayona-Vásquez, N. J. (2016). Complete mitochondrial genome of the porbeagle shark, . Mitochondrial DNA. Part B, Resources, 1(1), 730-731. https://doi.org/10.1080/23802359.2016.1233465
Díaz-Jaimes, Píndaro, et al. "Complete mitochondrial genome of the porbeagle shark, ." Mitochondrial DNA. Part B, Resources vol. 1,1 (2016): 730-731. doi: https://doi.org/10.1080/23802359.2016.1233465
Díaz-Jaimes P, Uribe-Alcocer M, Adams DH, Rangel-Morales JM, Bayona-Vásquez NJ. Complete mitochondrial genome of the porbeagle shark, . Mitochondrial DNA B Resour. 2016 Oct 03;1(1):730-731. doi: 10.1080/23802359.2016.1233465. PMID: 33473607; PMCID: PMC7799682.
Copy Download .nbib Format: NLM
Adapterama I: universal stubs and primers for 384 unique dual-indexed or 147,456 combinatorially-indexed Illumina libraries (iTru & iNext).

PeerJ

Glenn TC, Nilsen RA, Kieran TJ, Sanders JG, Bayona-Vásquez NJ, Finger JW, Pierson TW, Bentley KE, Hoffberg SL, Louha S, Garcia-De Leon FJ, Del Rio Portilla MA, Reed KD, Anderson JL, Meece JK, Aggrey SE, Rekaya R, Alabady M, Belanger M, Winker K, Faircloth BC.
PMID: 31616586
PeerJ. 2019 Oct 11;7:e7755. doi: 10.7717/peerj.7755. eCollection 2019.

Massively parallel DNA sequencing offers many benefits, but major inhibitory cost factors include: (1) start-up (i.e., purchasing initial reagents and equipment); (2) buy-in (i.e., getting the smallest possible amount of data from a run); and (3) sample preparation. Reducing...

Cite
Glenn TC, Nilsen RA, Kieran TJ, et al. Adapterama I: universal stubs and primers for 384 unique dual-indexed or 147,456 combinatorially-indexed Illumina libraries (iTru & iNext). PeerJ. 2019;7:e7755doi: 10.7717/peerj.7755.
Glenn, T. C., Nilsen, R. A., Kieran, T. J., Sanders, J. G., Bayona-Vásquez, N. J., Finger, J. W., Pierson, T. W., Bentley, K. E., Hoffberg, S. L., Louha, S., Garcia-De Leon, F. J., Del Rio Portilla, M. A., Reed, K. D., Anderson, J. L., Meece, J. K., Aggrey, S. E., Rekaya, R., Alabady, M., Belanger, M., Winker, K., & Faircloth, B. C. (2019). Adapterama I: universal stubs and primers for 384 unique dual-indexed or 147,456 combinatorially-indexed Illumina libraries (iTru & iNext). PeerJ, 7e7755. https://doi.org/10.7717/peerj.7755
Glenn, Travis C, et al. "Adapterama I: universal stubs and primers for 384 unique dual-indexed or 147,456 combinatorially-indexed Illumina libraries (iTru & iNext)." PeerJ vol. 7 (2019): e7755. doi: https://doi.org/10.7717/peerj.7755
Glenn TC, Nilsen RA, Kieran TJ, Sanders JG, Bayona-Vásquez NJ, Finger JW, Pierson TW, Bentley KE, Hoffberg SL, Louha S, Garcia-De Leon FJ, Del Rio Portilla MA, Reed KD, Anderson JL, Meece JK, Aggrey SE, Rekaya R, Alabady M, Belanger M, Winker K, Faircloth BC. Adapterama I: universal stubs and primers for 384 unique dual-indexed or 147,456 combinatorially-indexed Illumina libraries (iTru & iNext). PeerJ. 2019 Oct 11;7:e7755. doi: 10.7717/peerj.7755. eCollection 2019. PMID: 31616586; PMCID: PMC6791352.
Copy Download .nbib Format: NLM
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.

NPJ precision oncology

Gurule NJ, McCoach CE, Hinz TK, Merrick DT, Van Bokhoven A, Kim J, Patil T, Calhoun J, Nemenoff RA, Tan AC, Doebele RC, Heasley LE.
PMID: 34001994
NPJ Precis Oncol. 2021 May 17;5(1):41. doi: 10.1038/s41698-021-00181-4.

Tyrosine kinase inhibitors (TKIs) targeting EGFR-mutant lung cancers promote a range of tumor regression responses to yield variable residual disease, a likely incubator for acquired resistance. Herein, rapid transcriptional responses induced by TKIs early in treatment that associate with...

Cite
Gurule NJ, McCoach CE, Hinz TK, et al. A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. NPJ Precis Oncol. 2021;5(1):41doi: 10.1038/s41698-021-00181-4.
Gurule, N. J., McCoach, C. E., Hinz, T. K., Merrick, D. T., Van Bokhoven, A., Kim, J., Patil, T., Calhoun, J., Nemenoff, R. A., Tan, A. C., Doebele, R. C., & Heasley, L. E. (2021). A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. NPJ precision oncology, 5(1), 41. https://doi.org/10.1038/s41698-021-00181-4
Gurule, Natalia J, et al. "A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer." NPJ precision oncology vol. 5,1 (2021): 41. doi: https://doi.org/10.1038/s41698-021-00181-4
Gurule NJ, McCoach CE, Hinz TK, Merrick DT, Van Bokhoven A, Kim J, Patil T, Calhoun J, Nemenoff RA, Tan AC, Doebele RC, Heasley LE. A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. NPJ Precis Oncol. 2021 May 17;5(1):41. doi: 10.1038/s41698-021-00181-4. PMID: 34001994; PMCID: PMC8129124.
Copy Download .nbib Format: NLM
Scleral fixation of a dexamethasone intravitreal implant in a case of subluxated bag-intraocular lens complex.

Therapeutic advances in ophthalmology

Rangel CM, Moreno NJ, Parra MM.
PMID: 31309171
Ther Adv Ophthalmol. 2019 Jul 04;11:2515841419856520. doi: 10.1177/2515841419856520. eCollection 2019.

Macular edema is a condition of retinal tissue treated with anti-inflammatory agents including placement of an intravitreal sustained-release dexamethasone device, designed to deliver a controlled amount of the medication for a prolonged time, representing an excellent therapy. Nonetheless, the...

Cite
Rangel CM, Moreno NJ, Parra MM. Scleral fixation of a dexamethasone intravitreal implant in a case of subluxated bag-intraocular lens complex. Ther Adv Ophthalmol. 2019;11:2515841419856520doi: 10.1177/2515841419856520.
Rangel, C. M., Moreno, N. J., & Parra, M. M. (2019). Scleral fixation of a dexamethasone intravitreal implant in a case of subluxated bag-intraocular lens complex. Therapeutic advances in ophthalmology, 112515841419856520. https://doi.org/10.1177/2515841419856520
Rangel, Carlos M, et al. "Scleral fixation of a dexamethasone intravitreal implant in a case of subluxated bag-intraocular lens complex." Therapeutic advances in ophthalmology vol. 11 (2019): 2515841419856520. doi: https://doi.org/10.1177/2515841419856520
Rangel CM, Moreno NJ, Parra MM. Scleral fixation of a dexamethasone intravitreal implant in a case of subluxated bag-intraocular lens complex. Ther Adv Ophthalmol. 2019 Jul 04;11:2515841419856520. doi: 10.1177/2515841419856520. eCollection 2019. PMID: 31309171; PMCID: PMC6613052.
Copy Download .nbib Format: NLM
Correction: A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity.

PloS one

Yasgar A, Titus SA, Wang Y, Danchik C, Yang SM, Vasiliou V, Jadhav A, Maloney DJ, Simeonov A, Martinez NJ.
PMID: 29763427
PLoS One. 2018 May 15;13(5):e0197292. doi: 10.1371/journal.pone.0197292. eCollection 2018.

[This corrects the article DOI: 10.1371/journal.pone.0170937.].

Cite
Yasgar A, Titus SA, Wang Y, et al. Correction: A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity. PLoS One. 2018;13(5):e0197292doi: 10.1371/journal.pone.0197292.
Yasgar, A., Titus, S. A., Wang, Y., Danchik, C., Yang, S. M., Vasiliou, V., Jadhav, A., Maloney, D. J., Simeonov, A., & Martinez, N. J. (2018). Correction: A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity. PloS one, 13(5), e0197292. https://doi.org/10.1371/journal.pone.0197292
Yasgar, Adam, et al. "Correction: A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity." PloS one vol. 13,5 (2018): e0197292. doi: https://doi.org/10.1371/journal.pone.0197292
Yasgar A, Titus SA, Wang Y, Danchik C, Yang SM, Vasiliou V, Jadhav A, Maloney DJ, Simeonov A, Martinez NJ. Correction: A High-Content Assay Enables the Automated Screening and Identification of Small Molecules with Specific ALDH1A1-Inhibitory Activity. PLoS One. 2018 May 15;13(5):e0197292. doi: 10.1371/journal.pone.0197292. eCollection 2018. PMID: 29763427; PMCID: PMC5953492.
Copy Download .nbib Format: NLM
Gateway-compatible yeast one-hybrid screens.

CSH protocols

Deplancke B, Vermeirssen V, Arda HE, Martinez NJ, Walhout AJ.
PMID: 22485967
CSH Protoc. 2006 Oct 01;2006(5). doi: 10.1101/pdb.prot4590.

INTRODUCTIONProtein-DNA interactions (PDIs) between transcription factors (TFs) and their target genes form the backbone of transcription regulatory networks. Such PDIs can be identified with either a TF or a gene as a starting point. The Gateway-compatible yeast one-hybrid (Y1H)...

Cite
Deplancke B, Vermeirssen V, Arda HE, et al. Gateway-compatible yeast one-hybrid screens. CSH Protoc. 2006;2006(5)doi: 10.1101/pdb.prot4590.
Deplancke, B., Vermeirssen, V., Arda, H. E., Martinez, N. J., & Walhout, A. J. (2006). Gateway-compatible yeast one-hybrid screens. CSH protocols, 2006(5), . https://doi.org/10.1101/pdb.prot4590
Deplancke, Bart, et al. "Gateway-compatible yeast one-hybrid screens." CSH protocols vol. 2006,5 (2006). doi: https://doi.org/10.1101/pdb.prot4590
Deplancke B, Vermeirssen V, Arda HE, Martinez NJ, Walhout AJ. Gateway-compatible yeast one-hybrid screens. CSH Protoc. 2006 Oct 01;2006(5). doi: 10.1101/pdb.prot4590. PMID: 22485967.
Copy Download .nbib Format: NLM
Splenic salvage in hydatid disease.

Annals of Saudi medicine

Nangalia R, Al-Salem AH.
PMID: 17588002
Ann Saudi Med. 1993 Jan;13(1):88-90. doi: 10.5144/0256-4947.1993.88.

No abstract available.

Cite
Nangalia R, Al-Salem AH. Splenic salvage in hydatid disease. Ann Saudi Med. 1993;13(1):88-90doi: 10.5144/0256-4947.1993.88.
Nangalia, R., & Al-Salem, A. H. (1993). Splenic salvage in hydatid disease. Annals of Saudi medicine, 13(1), 88-90. https://doi.org/10.5144/0256-4947.1993.88
Nangalia, R, and Al-Salem, A H. "Splenic salvage in hydatid disease." Annals of Saudi medicine vol. 13,1 (1993): 88-90. doi: https://doi.org/10.5144/0256-4947.1993.88
Nangalia R, Al-Salem AH. Splenic salvage in hydatid disease. Ann Saudi Med. 1993 Jan;13(1):88-90. doi: 10.5144/0256-4947.1993.88. PMID: 17588002.
Copy Download .nbib Format: NLM
Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension.

The European respiratory journal

Braams NJ, Boon GJAM, de Man FS, van Es J, den Exter PL, Kroft LJM, Beenen LFM, Huisman MV, Nossent EJ, Boonstra A, Vonk Noordegraaf A, Ruigrok D, Klok FA, Bogaard HJ, Meijboom LJ.
PMID: 34112733
Eur Respir J. 2021 Dec 23;58(6). doi: 10.1183/13993003.00699-2021. Print 2021 Dec.

INTRODUCTION: The pulmonary arterial morphology of patients with pulmonary embolism (PE) is diverse and it is unclear how the different vascular lesions evolve after initiation of anticoagulant treatment. A better understanding of the evolution of computed tomography pulmonary angiography...

Cite
Braams NJ, Boon GJAM, de Man FS, et al. Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021;58(6)doi: 10.1183/13993003.00699-2021.
Braams, N. J., Boon, G. J. A. M., de Man, F. S., van Es, J., den Exter, P. L., Kroft, L. J. M., Beenen, L. F. M., Huisman, M. V., Nossent, E. J., Boonstra, A., Vonk Noordegraaf, A., Ruigrok, D., Klok, F. A., Bogaard, H. J., & Meijboom, L. J. (2021). Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension. The European respiratory journal, 58(6), . https://doi.org/10.1183/13993003.00699-2021
Braams, Natalia J, et al. "Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension." The European respiratory journal vol. 58,6 (2021). doi: https://doi.org/10.1183/13993003.00699-2021
Braams NJ, Boon GJAM, de Man FS, van Es J, den Exter PL, Kroft LJM, Beenen LFM, Huisman MV, Nossent EJ, Boonstra A, Vonk Noordegraaf A, Ruigrok D, Klok FA, Bogaard HJ, Meijboom LJ. Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021 Dec 23;58(6). doi: 10.1183/13993003.00699-2021. Print 2021 Dec. PMID: 34112733.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 47 entries